Joy A. Cavagnaro is the President and Founder of Access BIO, where she consults globally on science-based preclinical development strategies. She has over 40 years of experience in the biotechnology industry, and has served at the United States Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) and was appointed to Senior Biomedical Research Service. Dr. Cavagnaro was also the past Chair of the Regulatory Affairs Professional Society (RAPS), President of the National Capital Area Chapter of the Society of Toxicology (SOT), and recipient of the Society’s 2019 Arnold J. Lehman Award. She received her Ph.D. in Biochemistry from the University of North Carolina at Chapel Hill, followed by post-graduate work at Duke University and Boston University Medical Centers.